LSKL, Inhibitor of Thrombospondin TSP-1

LSKL, Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-β and prevents the progression of hepatic damage and fibrosis.

Price Not Available Inquiry LSKL, Inhibitor of Thrombospondin TSP-1 Supplier Page

Catalog Number	R1490
Molecular Formula	C21H42N6O5
CAS#	283609-79-0
Purity	>98%
Inchi	InChI=1S/C21H42N6O5/c1-12(2)9-14(23)19(30)27-17(11-28)21(32)25-15(7-5-6-8-22)20(31)26-16(18(24)29)10-13(3)4/h12-17,28H,5-11,22-23H2,1-4H3,(H2,24,29)(H,25,32)(H,26,31)(H,27,30)/t14-,15-,16-,17-/m0/s1
Inchi Key	YOKXDNNIFSAXBY-QAETUUGQSA-N
SMILES	CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N)N
Size	Inquiry
Supplier Page	https://www.creative-peptides.com/product/lskl-inhibitor-of-thrombospondin-tsp-1-item-r1490-2316.html